Ping Zhu
Abstract
从2005年报道JAK2 V617F突变发生于慢性骨髓增殖性疾病(myeloproliferative disorder,MPD)[1-3]以来,这个基因突变的发现改变了MPD的分类和诊断.以往MPD包含慢性粒细胞白血病(CML),真性红细胞增多症(PV),原发性血小板增多症(ET),和原发性骨髓纤维化(PMF),慢性中性粒细胞白血病(CNL),慢性嗜酸细胞白血病/高嗜酸细胞综合征(CEL/HES)等多种疾病。
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
从2005年报道JAK2 V617F突变发生于慢性骨髓增殖性疾病(myeloproliferative disorder,MPD)[1-3]以来,这个基因突变的发现改变了MPD的分类和诊断.以往MPD包含慢性粒细胞白血病(CML),真性红细胞增多症(PV),原发性血小板增多症(ET),和原发性骨髓纤维化(PMF),慢性中性粒细胞白血病(CNL),慢性嗜酸细胞白血病/高嗜酸细胞综合征(CEL/HES)等多种疾病。
Key concepts: Mutation, Myeloproliferative Disorders, Cancer research, Medicine, Internal medicine, Genetics, Biology, Gene